Which treatment for high-risk patients with DLBCL?

被引：0
|
作者：
Coiffier, Bertrand [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 12期
关键词：
HIGH-DOSE CHEMOTHERAPY; B-CELL LYMPHOMA; OPEN-LABEL; CHOP CHEMOTHERAPY; YOUNG-PATIENTS; PHASE-3; TRIAL; RITUXIMAB; DSHNHL;
D O I：
10.1016/S1470-2045(12)70507-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1180 / 1182
页数：4
相关论文
共 50 条
  • [41] TREATMENT OF HIGH-RISK CHORIOCARCINOMA
    BAGSHAWE, KD
    JOURNAL OF REPRODUCTIVE MEDICINE, 1984, 29 (11) : 813 - 820
  • [42] Treatment of High-Risk Neuroblastoma
    Krystal, Julie
    Foster, Jennifer H.
    CHILDREN-BASEL, 2023, 10 (08):
  • [43] Treatment of High-Risk Neuroblastoma
    Sung, Kiwoong
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
  • [44] Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
    Keenan T. Hartert
    Kerstin Wenzl
    Jordan E. Krull
    Michelle Manske
    Vivekananda Sarangi
    Yan Asmann
    Melissa C. Larson
    Matthew J. Maurer
    Susan Slager
    William R. Macon
    Rebecca L. King
    Andrew L. Feldman
    Anita K. Gandhi
    Brian K. Link
    Thomas M. Habermann
    Zhi-Zhang Yang
    Stephen M. Ansell
    James R. Cerhan
    Thomas E. Witzig
    Grzegorz S. Nowakowski
    Anne J. Novak
    Leukemia, 2021, 35 : 522 - 533
  • [45] Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
    Julius, Ulrich
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2018, 5 (02)
  • [46] Treatment options for multiple myeloma patients with high-risk disease
    Ailawadhi, Sikander
    Masood, Aisha
    Sher, Taimur
    Miller, Kena C.
    Wood, Margaret
    Lee, Kelvin
    Chanan-Khan, Asher
    MEDICAL ONCOLOGY, 2010, 27 : 53 - 61
  • [47] Pain Among High-Risk Patients on Methadone Maintenance Treatment
    Voon, Pauline
    Hayashi, Kanna
    Milloy, M-J
    Nguyen, Paul
    Wood, Evan
    Montaner, Julio
    Kerr, Thomas
    JOURNAL OF PAIN, 2015, 16 (09): : 887 - 894
  • [48] Emerging treatment options for patients with high-risk myelodysplastic syndrome
    Bewersdorf, Jan Philipp
    Carraway, Hetty
    Prebet, Thomas
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [49] Treatment options for multiple myeloma patients with high-risk disease
    Sikander Ailawadhi
    Aisha Masood
    Taimur Sher
    Kena C. Miller
    Margaret Wood
    Kelvin Lee
    Asher Chanan-Khan
    Medical Oncology, 2010, 27 : 53 - 61
  • [50] Significance of ONTARGET Results for the Treatment of cardiovascular High-risk Patients
    Eber, B.
    JOURNAL FUR KARDIOLOGIE, 2008, 15 (5-6): : 189 - 191
12345